Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
11 studies found for:    Open Studies | "Epistaxis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Epistaxis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Interventions: Drug: Bevacizumab;   Drug: placebo
2 Unknown  A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children
Condition: Epistaxis
Intervention: Procedure: Nasal Cautery
3 Unknown  Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Intervention: Drug: Thalidomide
4 Recruiting Long Term Results and Complications After Epistaxis Treatment
Condition: Nosebleed (Epistaxis) - Posterior or Anterior
Intervention:
5 Recruiting Double Versus Single Pledget Nasal Anesthesia for Transnasal Endoscopy
Conditions: Anesthesia;   Epistaxis
Interventions: Device: Double pledget nasal anesthesia (DPNA);   Device: Single pledget nasal anesthesia (SPNA)
6 Recruiting The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial.
Conditions: Epistaxis;   Blood Pressure
Interventions: Drug: Oxymetazoline 0.05%;   Drug: Phenylephrine 0.25%;   Drug: Lidocaine 1% plus epinephrine 1:100,000;   Drug: Bacteriostatic 0.9% NaCL
7 Unknown  Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Submucosal Bevacizumab
8 Recruiting A Novel Anterior Rhinoscopic Scoring Scale to Predict Nasal Insertability Before Transnasal Endoscopy
Conditions: Injury Due to Endoscopic Examination;   Transnasal Endoscopy Induced Epistaxis;   Transnasal Endoscopy Induced Nasal Pain
Interventions: Procedure: anterior meatoscopy;   Procedure: Nasal sniff test
9 Unknown  Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Bevacizumab
10 Not yet recruiting Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose
Condition: Telangiectasia, Hereditary Hemorrhagic
Intervention: Drug: bevacuzimab spray
11 Recruiting Iron Deficiency and Hereditary Haemorrhagic Telangiectasia
Condition: Hereditary Haemorrhagic Telangiectasia
Intervention: Drug: Ferrous sulphate 200mg oral tablet

Indicates status has not been verified in more than two years